OTC Markets OTCPK - Delayed Quote USD

Rapid Dose Therapeutics Corp. (RDTCF)

0.1800

0.0000

(0.00%)

At close: January 29 at 3:00:00 PM EST

Rapid Dose Therapeutics Advances Collaboration with Global Leader for Market-Ready QuickStrip(R) Nicotine in 2025

Burlington, Ontario--(Newsfile Corp. - January 28, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (RDT), a Canadian biotechnology company working with an international company in oral nicotine products, is pleased to announce the expansion of their collaboration through the continuation of the exclusive pre-commercialization agreement. This agreement aims to finalize the development of innovative, market-ready products projected for launch in 2025. The pre-commercialization agreement requires

Newsfile 2 days ago

RDTCF
0.00%
Rapid Dose Provides Update on Share Issuance in Debt Settlement with Creditors and Proposed Private Placement

Burlington, Ontario--(Newsfile Corp. - January 27, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that further to its press release dated December 9, 2024 (the "Initial Press Release"), announcing a proposed debt settlement (the "Shares for Debt Transaction") with certain of its creditors (the "Creditors") to issue an aggregate of up to 1,600,000 common shares (the "Settlement Shares") at $0.25 per share to such Creditors in exchange for ...

Newsfile 3 days ago

RDTCF
0.00%
Rapid Dose Completes Issuance of Shares as Payment of Directors' Fees

Burlington, Ontario--(Newsfile Corp. - January 16, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") is pleased to announce that it has completed its previously announced shares for debt transaction to issue common shares (the "Debt Shares") to its non-management directors (the "Directors") in exchange for the cancellation of directors' fees owing. Each of the five Directors was owed $10,000 in directors' fees for each of the fiscal quarters ended ...

Newsfile 14 days ago

RDTCF
0.00%
Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt

Burlington, Ontario--(Newsfile Corp. - January 7, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the "Notes") previously issued on its private placement financing (the "Financing"), and consistent with prior quarters, the Company intends to issue common shares ("Common Shares") in satisfaction of the accrued interest payable on December 31, 2024 under the terms of the Notes. The Company expects ...

Newsfile 23 days ago

RDTCF
0.00%
Rapid Dose Announces Proposed Issuance of Shares as Payment of Director Fees

Burlington, Ontario--(Newsfile Corp. - December 24, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announces that it has agreed with its non-management directors (the "Directors") to issue common shares (the "Debt Shares") to such Directors in exchange for the cancellation of director fees owing. Each of the five Directors is owed $10,000 in director fees for each of the fiscal quarters ended May 31, August 31 and November 30, 2024, ...

Newsfile last month

RDTCF
0.00%
Rapid Dose Announces Proposed Equity Private Placement Financing and Proposed Shares for Debt Settlement

Burlington, Ontario--(Newsfile Corp. - December 10, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that it plans to complete an equity private placement financing (the "Financing") for up to $6,000,000 of gross proceeds, consisting of up to 24,000,000 units (the "Units") at a price of $0.25 per Unit. Each Unit will consist of one (1) Common Share and one (1) Common Share Purchase Warrant (a "Warrant"). Each Warrant ...

Newsfile last month

RDTCF
0.00%
Rapid Dose Therapeutics Corp. Files Patent Application for Lidocaine Oral Thin Strip

Burlington, Ontario--(Newsfile Corp. - December 5, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian biotechnology company, is pleased to announce that it has filed a patent application for its Lidocaine Oral Thin Film Strip, with the Canadian Intellectual Property Office ("CIPO").Dentists commonly perform dental procedures using anesthesia administered through injection by needle, which is commonly preceded by a spray, gel, jelly, cream, or ointment. RDT is

Newsfile last month

RDTCF
0.00%
Rapid Dose Announces Closing of Final Tranche of Common Share Private Placement

Burlington, Ontario--(Newsfile Corp. - October 30, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") is pleased to announce that it has closed a second and final tranche of its previously announced equity private placement financing (the "Financing") for aggregate gross proceeds of $542,000.The proceeds of the Financing will be used for research and development, capital expansion, repayment of debt and general working capital requirements.The Financing allowed for a maxi

Newsfile 2 months ago

RDTCF
0.00%
Rapid Dose Announces Payment in Shares for Interest on Secured Debt

Burlington, Ontario--(Newsfile Corp. - October 1, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the "Notes") previously issued on its private placement financing (the "Financing"), the Company intends to issue common shares ("Common Shares") in satisfaction of the accrued interest payable on September 30, 2024 under the terms of the Financing and the Notes, and expects to issue the Common ...

Newsfile 3 months ago

RDTCF
0.00%
Rapid Dose Provides Update on Common Share Private Placement

Burlington, Ontario--(Newsfile Corp. - September 16, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that further to its press release dated August 7, 2024, regarding a proposed equity private placement financing (the "Financing"), the Company has received an extension from the Canadian Securities Exchange allowing it to close the Financing on or before October 29, 2024. This previously announced Financing contemplates an aggregate of up to $6,000,000 .

Newsfile 4 months ago

RDTCF
0.00%
Rapid Dose Announces Closing of First Tranche of Common Share Private Placement

Burlington, Ontario--(Newsfile Corp. - July 22, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") is pleased to announce that it has closed a first tranche of its previously announced equity private placement financing (the "Financing") for aggregate gross proceeds of $309,000.The proceeds of the Financing will be used for research and development, capital expansion, repayment of debt and general working capital requirements.The Financing allowed for a maximum of $6,000,

Newsfile 6 months ago

RDTCF
0.00%
Rapid Dose Therapeutics Announces Payment in Shares for Interest on Secured Debt

Burlington, Ontario--(Newsfile Corp. - July 2, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the "Notes") previously issued on its private placement financing (the "Financing"), the Company intends to issue common shares ("Common Shares") in satisfaction of the accrued interest payable on June 30, 2024 under the terms of the Financing and the Notes, and expects to issue the Common ...

Newsfile 6 months ago

RDTCF
0.00%
Rapid Dose Therapeutics Reports Fiscal Year 2024 Financial Results

Burlington, Ontario--(Newsfile Corp. - July 2, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), is pleased to announce the filing of its financial results for the year ended February 29, 2024. Mark Upsdell, Chairman and Chief Executive Officer, stated, "Over the past several years, our product roadmap has expanded from our Nutraceutical business to complementary markets such as Pharmaceutical, Dental, Nicotine, Cannabis and Vaccine products. These innovative products h

Newsfile 6 months ago

RDTCF
0.00%
Rapid Dose Therapeutics Vaccine Delivery Study Receives Mitacs Accelerate Grant

Burlington, Ontario--(Newsfile Corp. - June 25, 2024) - Rapid Dose Therapeutics Corp. ("RDT" or the "Company") trading on the Canadian Securities Exchange ("CSE") under the symbol DOSE is pleased to announce the recent award of a Mitacs Accelerate grant, with a value of $30,000 in May 2024 in addition to $55,000 in 2023, to continue the development of Thin Polymer Films for Vaccine Delivery Project, led by Prof. Alex Adronov, of McMaster University. This ...

Newsfile 7 months ago

RDTCF
0.00%
Rapid Dose Therapeutics Commits to NFL-Funded Clinical Trial Application

Burlington, Ontario--(Newsfile Corp. - May 29, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announces its collaboration in the National Football League (NFL) – funded clinical trial program entitled "Naturally Produced Cannabinoids for Pain Management and Neuroprotection from Concussion and Participation in Contact Sports" led by Dr. J. Patrick Neary and researchers at the University of Regina. RDT will partake in a randomized, two-arm clinical study, which is part

Newsfile 7 months ago

RDTCF
0.00%
Rapid Dose Therapeutics and McMaster University's Incorporation of Loratadine-Cyclodextrin Complexes in Oral Thin Films for Rapid Drug Delivery

Burlington, Ontario--(Newsfile Corp. - May 22, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") trading on the Canadian Securities Exchange ("CSE") under the symbol DOSE in partnership with McMaster University ("McMaster") is pleased to announce the publication of the results of their collaborative research project titled "Incorporation of Loratadine-Cyclodextrin Complexes in Oral Thin Films ("OTF") for Rapid Drug Delivery" in the Journal of Pharmaceutical Sciences.This

Newsfile 8 months ago

RDTCF
0.00%

Performance Overview

Return	RDTCF	S&P/TSX Composite index
YTD	0.00%	+4.82%
1-Year	+1,092.05%	+21.74%
3-Year	-57.14%	+24.43%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Rapid Dose Therapeutics Corp. (RDTCF)

Rapid Dose Therapeutics Advances Collaboration with Global Leader for Market-Ready QuickStrip(R) Nicotine in 2025

Rapid Dose Provides Update on Share Issuance in Debt Settlement with Creditors and Proposed Private Placement

Rapid Dose Completes Issuance of Shares as Payment of Directors' Fees

Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt

Rapid Dose Announces Proposed Issuance of Shares as Payment of Director Fees

Rapid Dose Announces Proposed Equity Private Placement Financing and Proposed Shares for Debt Settlement

Rapid Dose Therapeutics Corp. Files Patent Application for Lidocaine Oral Thin Strip

Rapid Dose Announces Closing of Final Tranche of Common Share Private Placement

Rapid Dose Announces Payment in Shares for Interest on Secured Debt

Rapid Dose Provides Update on Common Share Private Placement

Rapid Dose Announces Closing of First Tranche of Common Share Private Placement

Rapid Dose Therapeutics Announces Payment in Shares for Interest on Secured Debt

Rapid Dose Therapeutics Reports Fiscal Year 2024 Financial Results

Rapid Dose Therapeutics Vaccine Delivery Study Receives Mitacs Accelerate Grant

Rapid Dose Therapeutics Commits to NFL-Funded Clinical Trial Application

Rapid Dose Therapeutics and McMaster University's Incorporation of Loratadine-Cyclodextrin Complexes in Oral Thin Films for Rapid Drug Delivery

Performance Overview